Literature DB >> 8167536

Vascular disease: the next target for local molecular therapeutics.

J McEwan, A Henney, S Humphries.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8167536      PMCID： PMC2539884          DOI： 10.1136/bmj.308.6935.995

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  10 in total

1.  Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo.

Authors:  M Simons; E R Edelman; J L DeKeyser; R Langer; R D Rosenberg
Journal:  Nature       Date:  1992-09-03       Impact factor: 49.962

2.  Introduction of vascular smooth muscle cells expressing recombinant genes in vivo.

Authors:  G Plautz; E G Nabel; G J Nabel
Journal:  Circulation       Date:  1991-02       Impact factor: 29.690

3.  Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo.

Authors:  E G Nabel; Z Y Yang; G Plautz; R Forough; X Zhan; C C Haudenschild; T Maciag; G J Nabel
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

4.  Recombinant gene expression in vivo within endothelial cells of the arterial wall.

Authors:  E G Nabel; G Plautz; F M Boyce; J C Stanley; G J Nabel
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

5.  Implantation of vascular grafts lined with genetically modified endothelial cells.

Authors:  J M Wilson; L K Birinyi; R N Salomon; P Libby; A D Callow; R C Mulligan
Journal:  Science       Date:  1989-06-16       Impact factor: 47.728

6.  In vivo adenoviral vector-mediated gene transfer into balloon-injured rat carotid arteries.

Authors:  S W Lee; B C Trapnell; J J Rade; R Virmani; D A Dichek
Journal:  Circ Res       Date:  1993-11       Impact factor: 17.367

7.  Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Authors:  R Morishita; G H Gibbons; K E Ellison; M Nakajima; L Zhang; Y Kaneda; T Ogihara; V J Dzau
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

8.  In vivo gene transfer and expression in normal uninjured blood vessels using replication-deficient recombinant adenovirus vectors.

Authors:  P Lemarchand; M Jones; I Yamada; R G Crystal
Journal:  Circ Res       Date:  1993-05       Impact factor: 17.367

9.  Recombinant platelet-derived growth factor B gene expression in porcine arteries induce intimal hyperplasia in vivo.

Authors:  E G Nabel; Z Yang; S Liptay; H San; D Gordon; C C Haudenschild; G J Nabel
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

10.  Efficient and selective adenovirus-mediated gene transfer into vascular neointima.

Authors:  R J Guzman; P Lemarchand; R G Crystal; S E Epstein; T Finkel
Journal:  Circulation       Date:  1993-12       Impact factor: 29.690
  10 in total
  1 in total

1.  Delivery of Polymeric Nanoparticles to Target Vascular Diseases.

Authors:  Edward Agyare; Karunyna Kandimalla
Journal:  J Biomol Res Ther       Date:  2014-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.